Read more

April 09, 2020
1 min read
Save

Top stories in gastroenterology: Role of GI symptoms in COVID-19, FDA requests market withdrawal of Zantac

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A recent study from China suggests that COVID-19 should be suspected in patients with digestive symptoms who were possibly exposed to the novel coronavirus, even if they do not have common respiratory symptoms such as cough, shortness of breath, sore throat or fever. This was the top story in gastroenterology last week.

Another top story was about the FDA’s request for manufacturers to withdraw over-the-counter Zantac (ranitidine) products from the market.

Read these and more top stories in gastroenterology below:

Patients with COVID-19 GI symptoms experience delayed diagnosis, viral clearance

Patients who develop new-onset digestive symptoms, like diarrhea, after a possible exposure to COVID-19 should be suspected for the illness, according to research published in The American Journal of Gastroenterology. Read more.

Woman with stomach pain 
Patients who develop new-onset digestive symptoms, like diarrhea, after a possible exposure to COVID-19 should be suspected for the illness, according to research published in The American Journal of Gastroenterology.
Source: Adobe Stock

FDA recommends discontinuation of OTC Zantac

The FDA has requested that manufacturers withdraw all prescription and over-the-counter ranitidine drugs and advised patients to discontinue taking over-the-counter versions of the drug, according to an agency release. Read more.

VIDEO: Impact of COVID-19 on use of telehealth

William D. Chey, MD, from the Michigan Medicine Gastroenterology Clinic, Taubman Center at the University of Michigan, said COVID-19 has impacted the use of video visits with patients. Watch video.

VIDEO: Racial backlash as an Asian American physician due to COVID-19

William D. Chey, MD, from the Michigan Medicine Gastroenterology Clinic, Taubman Center at the University of Michigan, discusses in the fourth part of a five-part video series racial backlash as an Asian American physician during the COVID-19 pandemic. Watch video.

VIDEO: Impact of COVID-19 on IBD, clinical trials

In this exclusive video series, Stephen B. Hanauer, MD, medical director of the Digestive Health Center at Northwestern University Feinberg School of Medicine, discusses the impact of COVID-19 on the world of gastroenterology. Watch video.